The Pentagon has withdrawn its newly released testosterone screening guidelines for male service members, announcing the documents were posted in error and will be updated before any final policy takes effect.
Just days after issuing new clinical guidelines about mandatory testosterone-deficiency screening for male troops aged 30 and older, the Defense Department abruptly removed the documents from its website, leaving only interim guidance in place while officials reconsider the details. The Defense Health Agency had published the guidance on September 2, 2026, but the materials disappeared from public view the following day. Pentagon spokesman Sean Parnell’s press release had linked to the documents, but they were soon “temporarily rescinded to allow for updates,” as a U.S. official explained.
The policy reversal comes less than two months after Defense Secretary Pete Hegseth’s July announcement that testosterone screenings would become part of annual health checkups for male service members aged 30 and up, including both active duty and reservists. Hegseth’s move was pitched as a step to address hormone deficiencies, improve troops’ health, and boost operational performance.
But the guidance released on September 2 was taken down almost immediately. Tim Parlatore, a senior adviser to Hegseth, said the guidelines were posted inadvertently before receiving adequate review. “What was posted earlier this week was something that was a draft. It was not approved for release,” Parlatore said. He added, “Somebody had put it out there inadvertently. And so, we needed to pull that back because we need a lot more input to make sure that the information on that reflected the current science and medical science and medical guidance, as opposed to certain antiquated protocols.”
While the Pentagon says the goal is to ensure guidance that reflects the best available medical evidence, the episode raises questions about the department’s process for developing and implementing new health mandates affecting tens of thousands of service members.
For now, the interim guidance on testosterone-deficiency screening for active duty and reserve personnel “remains in effect,” according to a U.S. official. The ABC News report confirmed that the final clinical guidance has not yet been issued, with Pentagon officials promising that a revised version will be released “shortly.”
The withdrawn documents, according to Newsmax, would have required men aged 30 and older to complete annual questionnaires about symptoms of testosterone deficiency. If flagged, these could have led to blood tests and, in some cases, hormone therapy. The draft also included recommendations for screening women for hormonal issues, but would have limited testosterone treatment to diagnoses where evidence of effectiveness exists, such as Hypoactive Sexual Desire Disorder.
The Washington Examiner noted that for men under 30, testing would be voluntary unless there was a clear medical need or the service member requested it. The guidance also covered hormonal imbalances for female service members experiencing menopause or perimenopause, though officials did not clarify how treatment options might change in the future.
The now-withdrawn guidelines were the latest result of Secretary Hegseth’s campaign to boost military performance by addressing hormone issues. In July, he declared that testosterone screening and replacement therapy would help keep U.S. troops on the “leading edge of lethality,” according to Breitbart. This language signaled a shift in approach, treating hormone health as a matter of military readiness rather than a purely medical concern.
Despite the temporary reversal, the Pentagon maintained its commitment to the underlying goal. “The Department remains committed to addressing hormone deficiencies, protecting the long-term health of its Service members and enabling peak operational performance,” an unnamed Pentagon official told Breitbart.
Still, the confusion over policy rollout and removal points to a lack of clarity and coordination within Pentagon leadership. The chain of events, from Hegseth’s public push, to premature document release, to the quick retraction, suggests a gap between political messaging and the process for evidence-based policy.
While Pentagon officials blame the mishap on the premature release of a draft, they have provided no timeline for when final guidance will be ready or what changes are expected. It is also unclear who within the Defense Health Agency approved the posting, or what “antiquated protocols” Parlatore was referring to.
The episode has left military physicians and service members in limbo, as interim rules hold and final policy is delayed. The process highlights the risks of politicizing science, and the need for accountability when major health mandates are issued, then abruptly rescinded, with little transparency about the decision-making behind them.
America’s troops deserve a Pentagon that gets it right the first time, not a bureaucracy that fumbles policy and leaves service members guessing about what rules will govern their health and careers.
